Found 664 chains in Genus chains table. Displaying 601 - 650. Applied filters: Proteins

Search results query ec: 2.7.11.24

Total Genus Sequence Length pdb Title
106 349 2fsmX Mitogen activated protein kinase p38alpha (d176a+f327s) activating mutant form-b
109 349 2fsoX Mitogen activated protein kinase p38alpha (d176a) activating mutant
103 351 2fslX Mitogen activated protein kinase p38alpha (d176a+f327s) activating mutant form-a
106 348 2fstX Mitogen activated protein kinase p38alpha (d176a+f327l) activating mutant
96 349 2fa2A Crystal structure of fus3 without a peptide from ste5
103 356 2excX Inhibitor complex of jnk3
103 350 2ewaA Dual binding mode of pyridinylimidazole to map kinase p38
108 353 2f9gA Crystal structure of fus3 phosphorylated on tyr182
102 351 2f49A Crystal structure of fus3 in complex with a ste5 peptide
112 353 2erkA Phosphorylated map kinase erk2
101 353 2b9iA Crystal structure of fus3 with a docking motif from msg5
101 353 2b9jA Crystal structure of fus3 with a docking motif from far1
102 355 2bajA P38alpha bound to pyrazolourea
105 353 2b9hA Crystal structure of fus3 with a docking motif from ste7
100 353 2b9fA Crystal structure of non-phosphorylated fus3
104 349 2bakA P38alpha map kinase bound to mpaq
106 349 2balA P38alpha map kinase bound to pyrazoloamine
107 347 2baqA P38alpha bound to ro3201195
106 355 2b1pA Inhibitor complex of jnk3
104 348 1zyjA Human p38 map kinase in complex with inhibitor 1a
107 351 1zzlA Crystal structure of p38 with triazolopyridine
109 348 1zz2A Two classes of p38alpha map kinase inhibitors having a common diphenylether core but exhibiting divergent binding modes
100 348 1ywrA Crystal structure analysis of inactive p38 kinase domain in complex with a monocyclic pyrazolone inhibitor
102 350 1yw2A Mutated mus musculus p38 kinase (mp38)
106 356 1yqjA Crystal structure of p38 alpha in complex with a selective pyridazine inhibitor
107 347 1wfcA Structure of apo, unphosphorylated, p38 mitogen activated protein kinase p38 (p38 map kinase) the mammalian homologue of the yeast hog1 protein
101 350 1wzyA Crystal structure of human erk2 complexed with a pyrazolopyridazine derivative
112 351 1wbvA Identification of novel p38 alpha map kinase inhibitors using fragment-based lead generation.
103 351 1w84A P38 kinase crystal structure in complex with small molecule inhibitor
105 351 1wboA Fragment based p38 inhibitors
110 351 1w82A P38 kinase crystal structure in complex with small molecule inhibitor
113 351 1wbtA Identification of novel p38 alpha map kinase inhibitors using fragment-based lead generation.
108 351 1wbsA Identification of novel p38 alpha map kinase inhibitors using fragment-based lead generation.
106 351 1wbwA Identification of novel p38 alpha map kinase inhibitors using fragment-based lead generation.
108 351 1w7hA P38 kinase crystal structure in complex with small molecule inhibitor
111 351 1wbnA Fragment based p38 inhibitors
109 351 1w83A P38 kinase crystal structure in complex with small molecule inhibitor
88 355 1ukiA Structural basis for the selective inhibition of jnk1 by the scaffolding protein jip1 and sp600125
93 355 1ukhA Structural basis for the selective inhibition of jnk1 by the scaffolding protein jip1 and sp600125
103 350 1tvoA The structure of erk2 in complex with a small molecule inhibitor
105 348 1r39A The structure of p38alpha
108 349 1r3cA The structure of p38alpha c162s mutant
103 356 1pmnA Crystal structure of jnk3 in complex with an imidazole-pyrimidine inhibitor
100 356 1pmuA The crystal structure of jnk3 in complex with a phenantroline inhibitor
99 356 1pmvA The structure of jnk3 in complex with a dihydroanthrapyrazole inhibitor
107 345 1pmeA Structure of penta mutant human erk2 map kinase complexed with a specific inhibitor of human p38 map kinase
112 348 1oz1A P38 mitogen-activated kinase in complex with 4-azaindole inhibitor
112 349 1oveA The structure of p38 alpha in complex with a dihydroquinolinone
110 348 1oukA The structure of p38 alpha in complex with a pyridinylimidazole inhibitor
107 350 1ouyA The structure of p38 alpha in complex with a dihydropyrido-pyrimidine inhibitor